Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Statistics

Total Valuation

AVDL has a market cap or net worth of $1.24 billion. The enterprise value is $1.21 billion.

Market Cap	1.24B
Enterprise Value	1.21B

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024, before market open.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

AVDL has 96.27 million shares outstanding. The number of shares has increased by 39.29% in one year.

Shares Outstanding	96.27M
Shares Change (YoY)	+39.29%
Shares Change (QoQ)	+4.86%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	84.49%
Float	83.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	132.51
PS Ratio	12.47
Forward PS	5.24
PB Ratio	17.68
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	12.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.54.

Current Ratio	2.82
Quick Ratio	2.37
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.25

Financial Efficiency

Return on equity (ROE) is -99.52% and return on invested capital (ROIC) is -45.19%.

Return on Equity (ROE)	-99.52%
Return on Assets (ROA)	-34.44%
Return on Capital (ROIC)	-45.19%
Revenue Per Employee	$617,851
Profits Per Employee	-$689,766
Employee Count	154
Asset Turnover	0.53
Inventory Turnover	0.69

Taxes

Income Tax	-427,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.43% in the last 52 weeks. The beta is 1.63, so AVDL's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	+31.43%
50-Day Moving Average	13.82
200-Day Moving Average	15.26
Relative Strength Index (RSI)	43.31
Average Volume (20 Days)	609,839

Short Selling Information

Short Interest	10.19M
Short Previous Month	10.97M
Short % of Shares Out	12.10%
Short % of Float	n/a
Short Ratio (days to cover)	12.45

Income Statement

In the last 12 months, AVDL had revenue of $95.15 million and -$106.22 million in losses. Loss per share was -$1.16.

Revenue	95.15M
Gross Profit	90.03M
Operating Income	-98.79M
Pretax Income	-106.65M
Net Income	-106.22M
EBITDA	-97.23M
EBIT	-98.79M
Loss Per Share	-$1.16

Balance Sheet

The company has $71.38 million in cash and $37.67 million in debt, giving a net cash position of $33.72 million or $0.35 per share.

Cash & Cash Equivalents	71.38M
Total Debt	37.67M
Net Cash	33.72M
Net Cash Per Share	$0.35
Equity (Book Value)	70.29M
Book Value Per Share	0.73
Working Capital	81.17M

Cash Flow

Operating Cash Flow	-114.15M
Capital Expenditures	n/a
Free Cash Flow	-114.15M
FCF Per Share	-$1.19

Margins

Gross margin is 94.62%, with operating and profit margins of -103.82% and -111.64%.

Gross Margin	94.62%
Operating Margin	-103.82%
Pretax Margin	-112.09%
Profit Margin	-111.64%
EBITDA Margin	-102.19%
EBIT Margin	-103.82%
FCF Margin	-119.96%

Dividends & Yields

AVDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.29%
Shareholder Yield	-39.29%
Earnings Yield	-8.54%
FCF Yield	-9.18%

Analyst Forecast

The average price target for AVDL is $24.17, which is 87.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.17
Price Target Difference	87.07%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	80.18%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AVDL has an Altman Z-Score of 2.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.7
Piotroski F-Score	1